Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Ceases Trading, Begins Liquidation of Assets

NEW YORK (GenomeWeb News) - Tripos yesterday ceased trading its shares and began to liquidate its assets, moves which are in line with plans the company laid out after selling both of its revenue-generating businesses earlier this year.
 
Tripos sold its Discovery Research business to Commonwealth Bio in May for as much as $2.15 million and it sold its Discovery Informatics business to Vector Capital in March for $26 million. 
 
Today, Mellon Investor Services will begin an initial a distribution of $.47 a share to Tripos shareholders.
 
Tripos said it has formed a liquidating trust that will dispose of remaining assets and liabilities following the initial distribution. The company estimates these assets to be worth around $4 million, primarily in cash.
In addition to the cash distribution, all shareholders will receive a "beneficial interest" in the liquidating trust.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.